1-Deoxynojirimycin (CAS 19130-96-2): A Potent Glycosidase Inhibitor for Research and Development

Explore the multifaceted applications of this crucial iminosugar in metabolic health and beyond.

Get a Quote & Sample

Product Advantages

Metabolic Health Support

The ability to inhibit alpha-glucosidase enzymes makes 1-Deoxynojirimycin a key compound for exploring therapeutic avenues in metabolic disorders like diabetes, by controlling blood sugar spikes.

Neuroprotection Potential

Research indicates that DNJ may play a role in mitigating neurodegeneration by influencing glycan processing and endoplasmic reticulum stress, offering hope for neurological condition research.

Broad Biological Activity

From inhibiting viral glycoprotein maturation to its presence in natural sources like mulberry leaves, 1-Deoxynojirimycin showcases diverse biological activities relevant to multiple research fields.

Key Applications

Metabolic Research

Studying the impact of 1-Deoxynojirimycin on carbohydrate metabolism and blood sugar regulation is crucial for understanding diabetes and related conditions.

Neuroscience Investigations

Delve into the potential of DNJ to influence neuroinflammatory pathways and neuronal survival, a promising area for neurodegenerative disease research.

Antiviral Studies

The mechanism by which 1-Deoxynojirimycin hinders viral glycoprotein processing offers valuable insights for antiviral drug discovery.

Biochemical Assays

Utilize 1-Deoxynojirimycin as a precise inhibitor in various biochemical assays to elucidate enzyme functions and pathways.